English | Español
Patient Daily | Feb 26, 2026

New study identifies multiple paths for therapy resistance in triple-negative breast cancer
Patient Daily | Feb 26, 2026

FDA shifts stance on drug approvals with move toward single pivotal trial
Patient Daily | Feb 26, 2026

Atara stock rises after report questions FDA’s rejection of cell therapy
Patient Daily | Feb 26, 2026

PRI President Pipes on 340B drug pricing: ‘Patients ultimately pay the price’
Patient Daily | Feb 25, 2026

Legal reporter: GOP has figured out ‘big money is getting in bed with mass tort lawyers’
Patient Daily | Feb 25, 2026

LB Pharma navigates tough markets for successful IPO after promising schizophrenia drug data
Patient Daily | Feb 25, 2026

FARE receives $2.5 million from National Peanut Board for food allergy research
Patient Daily | Feb 25, 2026

BlackDoctor.org calls for reforms to federal 340B drug pricing program

Trending
+ Regulatory
Patient Daily | Mar 30, 2026

Freedom Foundation CEO Meeks on 340B: 'The program has morphed into a veritable ATM for hospitals'
+ Pharmaceuticals
Patient Daily | Mar 27, 2026

Bayer asks Supreme Court to protect federal regulation from state tort litigation
+ Pharmaceuticals
Patient Daily | Apr 1, 2026

Alliance for Consumers releases update on trial law firm political donations
+ Regulatory
A. D. Brady | Mar 30, 2026

Consumer Choice Advocate: RFK Jr. helped ‘dubious claims gain credibility in courtrooms’